Falling for five consecutive days, Cresco Labs ended the session at $1.74 (down 0.54%)

A quick look at yesterday: during yesterday's session, Cresco Labs toiled and struggled for upward momentum before closing at $1.74. By the close, the the medical marijuana company suffered a 0.95 cents or 0.54% loss.

United States Building Permits (Feb) is next today at 12:30 UTC.

Trend-following investors would be interested to note that the MACD index is indicating that momentum is shifting from bullish to bearish following a negative crossover. When the MACD falls below the signal line, it is typically considered to be a bearish development favoring short positions. According to asset volatility analysis, Cresco Labs's lower Bollinger Band® is at $1.67, indicating that the asset has overextended to the downside and could, therefore, bounce back as buyers look for bargains.

All in all, the technical analysis suggests Cresco Labs has no clear-cut direction.

Cresco Labs was not the only decliner in the health care sector; Thermo Fisher Scientific closed at $542.7 (down 2.39%).

On the other hand, positive performances could be seen by looking at other health care stocks as Amgen traded at $234.9 after closing yesterday's trading day at $230.58 (up 1.87%). Bristol-Myers Squibb Company was up 1.52%.

Some optimism can drawn from the fact that United States Initial Jobless Claims is projected to outperform its last figure with 205,000. It previously stood at 211,000; data will be released today at 12:30 UTC.

Furthermore, United States Philadelphia Fed Manufacturing Index (Mar) will be released today at 12:30 UTC. United States Building Permits (Feb) scheduled to come out today at 12:30 UTC.

Having soared to a high of $6.53 approximately 11 months ago, the medical marijuana company is now trading 73.21% lower.